ライフサイエンスコーパス: ABPM

1 ABPM 24-hr systolic blood pressure (SBP) (133.9+/-14.3 v

2 ABPM has allowed detailed assessment of circadian blood

3 The immunopathology of ABPA, ABPM, and SAFS is incompletely understood.

4 omodulating therapies in patients with ABPA, ABPM, and SAFS requires additional larger studies.

5 ly associated with greater elevations in all ABPM indexes except for nighttime systolic indexed BP, a

6 d (2) HMWr was inversely associated with all ABPM indexes.

7 tervals can be accurately estimated using an ABPM.

8 Twenty participants wore an ABPM for three hours and a data logger which synchronous

9 estigated the association between clinic and ABPM with an established biomarker of atherosclerosis (i

10 HBPM and ABPM were close according to Pearson bivariate correlati

11 HBPM and ABPM were close according to Pearson bivariate correlati

12 Within-visit and ABPM variability in SBP were also lower in the amlodipin

13 Awake ABPM and nurse-determined BP measurements were lower tha

14 Twenty-four were hypertensive (awake ABPM>135/85 mm Hg and clinic/RN BP>140/90 mm Hg) before

15 , normotensive donors had no change in awake ABPM pressure (pre 121 +/- 1/75 +/- 2 vs. post 120 +/- 1

16 oportion decreased to 11% overall with awake ABPM findings (>135/85 mmHg).

17 ction between blood pressure (as assessed by ABPM) and the heart, interest is growing in the applicat

18 nts (24%) were classified as hypertensive by ABPM criteria and 29 (17%) by clinic blood pressure (BP)

19 inclusion criteria as blacks and showing, by ABPM, daytime mean arterial pressure (MAP) in the same r

20 This review describes ABPM and HBPM procedures, the blood pressure phenotypic

21 the development of Th2 responses seen during ABPM.

22 tment, there was a reduction in average 24-h ABPM by 14/7 mm Hg (systolic: 150 +/- 16 mm Hg vs. 136 +

23 60/100 mm Hg and diagnosis confirmed by 24-h ABPM of >/=130/80 mm Hg) who underwent catheter-based RD

24 Two hundred twenty-one patients had ABPM, and 142 patients had echocardiographic results ava

25 also measured the relationship between HBPM, ABPM, and organ damage as measured by albuminuria and le

26 also measured the relationship between HBPM, ABPM, and organ damage as measured by albuminuria and le

27 as assessed by clinic, daytime, and 24-hour ABPM.

28 However, ABPM has important uses in assessing blood pressure as w

29 ght-to-total adiponectin ratio (HMWr), 24-hr ABPM, and dual x-ray absorptiometry measures of fat mass

30 Measurement variability (SD in ABPM) and the effects of misclassification were greatest

31 using an ambulatory blood pressure monitor (ABPM) with single lead ECG.

32 inamap; Critikon), ambulatory BP monitoring (ABPM) findings, and standardized BP values determined by

33 confirmed by 24-h ambulatory BP monitoring (ABPM).

34 BP) on ambulatory blood pressure monitoring (ABPM) 157 +/- 22 mm Hg, despite medication with 5.4 +/-

35 linic: ambulatory blood pressure monitoring (ABPM) and home blood pressure monitoring (HBPM).

36 rgoing ambulatory blood pressure monitoring (ABPM) and the number of publications using this techniqu

37 nce of ambulatory blood pressure monitoring (ABPM) for risk stratification in renal transplant patien

38 M with ambulatory blood pressure monitoring (ABPM) for the diagnosis of uncontrolled hypertension in

39 M with ambulatory blood pressure monitoring (ABPM) for the diagnosis of uncontrolled hypertension in

40 Ambulatory blood pressure monitoring (ABPM) has emerged as a valuable clinical and research to

41 in and ambulatory blood pressure monitoring (ABPM) in 33 pediatric renal transplant recipients (TXP),

42 ure by ambulatory blood pressure monitoring (ABPM) in treated hypertensive blacks and whites whose da

43 Ambulatory blood pressure monitoring (ABPM) is the preferred method to characterize blood pres

44 formed ambulatory blood pressure monitoring (ABPM) to assess the efficacy of the procedure.

45 , 24-h ambulatory blood-pressure monitoring (ABPM) was also studied.

46 24-hr ambulatory blood pressure monitoring (ABPM) were obtained.

47 years, ambulatory blood pressure monitoring (ABPM), facilitated by user-friendly instrumentation, has

48 n 24 h ambulatory blood-pressure monitoring (ABPM).

49 ], and ambulatory blood pressure monitoring [ABPM]), clinical, and renal characteristics (iothalamate

50 Allergic bronchopulmonary mycosis (ABPM) is a hypersensitivity lung disease in which fungal

51 istics of allergic bronchopulmonary mycosis (ABPM).

52 n form of allergic bronchopulmonary mycosis (ABPM); other fungi, including Candida, Penicillium, and

53 t, interest is growing in the application of ABPM to the practice of nephrology.

54 r discusses some of the technical aspects of ABPM, followed by a review of five areas of clinical res

55 to withhold or alter therapy on the basis of ABPM readings is testimony to its clinical value in the

56 The characteristics of ABPM include severe asthma, eosinophilia, markedly incre

57 ing on 7 consecutive days, within 15 days of ABPM.

58 ing on 7 consecutive days, within 15 days of ABPM.

59 We also compared development of ABPM in young and mature mice and did not find any diffe

60 chronic inflammation, and the development of ABPM pathology in C. neoformans-infected lungs.

61 Detailed evaluations of ABPM findings, GFR, and urinary protein levels are warra

62 barriers to the successful implementation of ABPM and HBPM in clinical practice, proposes core compet

63 Using a mouse model of ABPM caused by Cryptococcus neoformans infection of C57B

64 ng blood pressure, as well as the utility of ABPM in several situations.

65 efined as a reduction of mean systolic BP on ABPM by 10 mm Hg or more at 6 months after RDN.

66 Six months after RDN, mean systolic BP on ABPM was significantly reduced from 157 +/- 22 mm Hg to

67 01), independent of mean SBP in clinic or on ABPM.

68 of renal denervation or a sham procedure on ABPM measurements 6 months post-randomization.

69 Variability on ABPM was a weaker predictor, but all measures of variabi

70 olic BP either at HBPM (R=0.42; P=0.0002) or ABPM (R=0.25; P=0.03).

71 olic BP either at HBPM (R=0.42; P=0.0002) or ABPM (R=0.25; P=0.03).

72 ft ventricular mass and BP either at HBPM or ABPM.

73 ft ventricular mass and BP either at HBPM or ABPM.

74 hypertension in kidney transplants requires ABPM.

75 dy-state" fungal infection and the resultant ABPM pathology.

76 ation with LVH supports the case for routine ABPM and cardiac structure evaluation as the standard of

77 Evidence supports ABPM as the reference standard for confirming elevated o

78 In the ABPM substudy, reduced variability in daytime SBP in the

79 lack of reimbursement for performance of the ABPM procedure, the growth in its usage and the willingn

80 In patients (n = 36) who underwent ABPM 6 months after treatment, there was a reduction in

81 black patients in our programs who underwent ABPM and met the above criteria were included in this st

82 iew of five areas of clinical research using ABPM, and which are relevant to renal medicine: microalb

83 he clinical setting, pediatric studies using ABPM to evaluate elevated blood pressure have shown that

84 Controversy exists about whether ABPM or HBPM is superior for estimating risk for cardiov

85 re in kidney transplants when evaluated with ABPM mainly as a result of increased sleep systolic BP.

86 these have not been studied in patients with ABPM and SAFS.